Theranostic gas-generating nanoparticles for targeted ultrasound imaging and treatment of neuroblastoma

Journal of Controlled Release

Volumn 223, Issue , 2016, Pages 197-206

  Lee, Jangwook ^a,b   Min, Hyun Su ^b   You, Dong Gil ^b   Kim, Kwangmeyung ^b   Kwon, Ick Chan ^b   Rhim, Taiyoun ^a   Lee, Kuen Yong ^a  

^a Hanyang University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

Gas generating nanoparticle; Neuroblastoma; Rabies virus glycoprotein; Theranostic system

Indexed keywords

CALCIUM CARBONATE; CARBON; CARBON DIOXIDE; DIAGNOSIS; GAS GENERATORS; GLYCOPROTEINS; MAMMALS; NANOPARTICLES; ORGANIC POLYMERS; POLYMERS; TUMORS; ULTRASONIC APPLICATIONS; ULTRASONIC IMAGING; VIRUSES;

CLINICAL APPLICATION; GENERATING NANOPARTICLES; INTRAVENOUS ADMINISTRATION; NEUROBLASTOMAS; POLY(D ,L-LACTIDE-CO- GLYCOLIDE); POLYMER NANOPARTICLES; POLYMERIC NANOPARTICLES; THERANOSTIC SYSTEM;

DISEASES;

CALCIUM CARBONATE; CALCIUM ION; CARBON DIOXIDE; GAS GENERATING POLYMER NANOPARTICLE; NANOPARTICLE; POLYGLACTIN; POLYMER; RABIES VIRUS GLYCOPROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; ANTINEOPLASTIC AGENT; GLYCOPROTEIN; LACTIC ACID; PEPTIDE FRAGMENT; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; RABIES VIRUS GLYCOPROTEIN PEPTIDE; VIRAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD FLOW; CELL DEATH; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; ECHOGRAPHY; IN VITRO STUDY; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; NANOENCAPSULATION; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABIES VIRUS; SURFACE PROPERTY; THERANOSTIC NANOMEDICINE; TUMOR DIAGNOSIS; TUMOR GROWTH; ANIMAL; CELL SURVIVAL; CHEMISTRY; DIAGNOSTIC IMAGING; DRUG EFFECTS; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME; ULTRASOUND;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCIUM CARBONATE; CARBON DIOXIDE; CELL LINE, TUMOR; CELL SURVIVAL; DIAGNOSTIC IMAGING; GLYCOPROTEINS; LACTIC ACID; MALE; MICE, NUDE; NANOPARTICLES; NEUROBLASTOMA; PEPTIDE FRAGMENTS; POLYGLYCOLIC ACID; TUMOR BURDEN; ULTRASONIC WAVES; VIRAL PROTEINS;

EID: 84953270962     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.12.051     Document Type: Article

References (39)

1. J.V. Frangioni New technologies for human cancer imaging J. Clin. Oncol. 26 2008 4012 4021
2. K.M. Hasebroock, and N.J. Serkova Toxicity of MRI and CT contrast agents Expert Opin. Drug Metab. Toxicol. 5 2009 403 416
3. C. Rydahl, H.S. Thomsen, and P. Marckmann High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent Investig. Radiol. 43 2008 141 144
4. F.D. Pashankar, M.S. O'Dorisio, and Y. Menda MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use J. Nucl. Med. 46 2005 55S 61S
5. S. Nie, Y. Xing, G.J. Kim, and J.W. Simons Nanotechnology applications in cancer Annu. Rev. Biomed. Eng. 9 2007 257 288
6. J.R. Lindner Microbubbles in medical imaging: current applications and future directions Nat. Rev. Drug Discov. 3 2004 527 533
7. A.L. Klibanov Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications Investig. Radiol. 41 2006 354 362
8. X. Xiong, F. Zhao, M. Shi, H. Yang, and Y. Liu Polymeric microbubbles for ultrasonic molecular imaging and targeted therapeutics J. Biomater. Sci. Polym. Ed. 22 2011 417 428
9. E. Kang, H.S. Min, J. Lee, M.H. Han, H.J. Ahn, I.C. Yoon, K. Choi, K. Kim, K. Park, and I.C. Kwon Nanobubbles from gas-generating polymeric nanoparticles: ultrasound imaging of living subjects Angew. Chem. Int. Ed. 49 2010 524 528
10. M.-M. Néstor, N.-P.E. Kei, N.-A.M. Guadalupe, M.-E.S. Elisa, G.-Q. Adriana, and Q.-G. David Preparation and in vitro evaluation of poly (d, l-lactide-co-glycolide) air-filled nanocapsules as a contrast agent for ultrasound imaging Ultrasonics 51 2011 839 845
11. B. Felice, M.P. Prabhakaran, A.P. Rodríguez, and S. Ramakrishna Drug delivery vehicles on a nano-engineering perspective Mater. Sci. Eng. 41 2014 178 195
12. S.M. Janib, A.S. Moses, and J.A. MacKay Imaging and drug delivery using theranostic nanoparticles Adv. Drug Deliv. Rev. 62 2010 1052 1063
13. K. Cho, X. Wang, S. Nie, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14 2008 1310 1316
14. I. Bala, S. Hariharan, and M.R. Kumar PLGA nanoparticles in drug delivery: the state of the art Crit. Rev. Ther. Drug Carrier Syst. 21 2004 36
15. P. Kumar, H. Wu, J.L. McBride, K.-E. Jung, M.H. Kim, B.L. Davidson, S.K. Lee, P. Shankar, and N. Manjunath Transvascular delivery of small interfering RNA to the central nervous system Nature 448 2007 39 43
16. D.W. Hwang, S. Son, J. Jang, H. Youn, S. Lee, D. Lee, Y.-S. Lee, J.M. Jeong, W.J. Kim, and D.S. Lee A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA Biomaterials 32 2011 4968 4975
17. B.B. Goldberg, J.-B. Liu, and F. Forsberg Ultrasound contrast agents: a review Ultrasound Med. Biol. 20 1994 319 333
18. S.R. Kerns, and I. Hawkins Jr. Carbon dioxide digital subtraction angiography: expanding applications and technical evolution AJR Am. J. Roentgenol. 164 1995 735 741
19. 2 gas-forming agents Int. J. Pharm. 239 2002 81 91
20. R. Liu, D. Li, B. He, X. Xu, M. Sheng, Y. Lai, G. Wang, and Z. Gu Anti-tumor drug delivery of pH-sensitive poly (ethylene glycol)-poly (l-histidine-)-poly (l-lactide) nanoparticles J. Control. Release 152 2011 49 56
21. A.J. Wood, W.E. Evans, and H.L. McLeod Pharmacogenomics - drug disposition, drug targets, and side effects N. Engl. J. Med. 348 2003 538 549
22. M.M. Gottesman Mechanisms of cancer drug resistance Annu. Rev. Med. 53 2002 615 627
23. A.L. Edinger, and C.B. Thompson Death by design: apoptosis, necrosis and autophagy Curr. Opin. Cell Biol. 16 2004 663 669
24. J.H. Kwon, S.H. Bae, J.Y. Kim, B.O. Choi, H.S. Jang, J.W. Jang, J.Y. Choi, S.K. Yoon, and K.W. Chung Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer BMC Cancer 10 2010 475
25. L. Zhang, H. Zhu, C. Jin, K. Zhou, K. Li, H. Su, W. Chen, J. Bai, and Z. Wang High-intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins Eur. Radiol. 19 2009 437 445
26. M.G. Hollingshead Antitumor efficacy testing in rodents J. Natl. Cancer Inst. 100 2008 1500 1510
27. E. Stride, and N. Saffari Microbubble ultrasound contrast agents: a review Proc. Inst. Mech. Eng. H J. Eng. Med. 217 2003 429 447
28. R. Suzuki, T. Takizawa, Y. Negishi, K. Hagisawa, K. Tanaka, K. Sawamura, N. Utoguchi, T. Nishioka, and K. Maruyama Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound J. Control. Release 117 2007 130 136
29. C.-J. Ke, T.-Y. Su, H.-L. Chen, H.-L. Liu, W.-L. Chiang, P.-C. Chu, Y. Xia, and H.-W. Sung Smart multifunctional hollow microspheres for the quick release of drugs in intracellular lysosomal compartments Angew. Chem. 123 2011 8236 8239
30. 2 bubbles to induce transient cavitation, lysosomal rupturing, and cell necrosis Angew. Chem. 124 2012 10236 10240
31. K.J. Widder, J.L. Barnhart, Method of magnetic resonance imaging using diamagnetic contrast, in Molecular Biosystems, Inc US. 5315997A (1994).
32. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Théry, and S. Amigorena Antigen presentation and T cell stimulation by dendritic cells Annu. Rev. Immunol. 20 2002 621 667
33. Y. Zhou, Z. Wang, Y. Chen, H. Shen, Z. Luo, A. Li, Q. Wang, H. Ran, P. Li, and W. Song Microbubbles from gas-generating perfluorohexane nanoemulsions for targeted temperature-sensitive ultrasonography and synergistic HIFU ablation of tumors Adv. Mater. 25 2013 4123 4130
34. K.H. Min, H.S. Min, H.J. Lee, D.J. Park, J.Y. Yhee, K. Kim, I.C. Kwon, S.Y. Jeong, O.F. Silvestre, and X. Chen pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers ACS Nano 9 2015 134 145
35. H. Hentze, X. Lin, M. Choi, and A. Porter Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin Cell Death Differ. 10 2003 956 968
36. R. Kircheis, E. Ostermann, M.F. Wolschek, C. Lichtenberger, C. Magin-Lachmann, L. Wightman, M. Kursa, and E. Wagner Tumor-targeted gene delivery of tumor necrosis factor-α induces tumor necrosis and tumor regression without systemic toxicity Cancer Gene Ther. 9 2002 673 680
37. R.K. Amaravadi, and C.B. Thompson The roles of therapy-induced autophagy and necrosis in cancer treatment Clin. Cancer Res. 13 2007 7271 7279
38. N. Festjens, T.V. Berghe, and P. Vandenabeele Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response Biochim. Biophys. Acta Bioenerg. 1757 2006 1371 1387
39. K. Degenhardt, R. Mathew, B. Beaudoin, K. Bray, D. Anderson, G. Chen, C. Mukherjee, Y. Shi, C. Gélinas, and Y. Fan Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis Cancer Cell 10 2006 51 64